Intentionally Simple. No strings, cords—or Sonographer—attached.
The world’s first ultrasound-based system designed specifically to help you apply spinal and epidural anesthesia with automated detection of epidural location and depth.
February 27, 2017 | Accuro™ in Rome used in world's first image-guided epidural in patient with rare neurological condition
December 6, 2016 | Press Release RIVANNA Announces Multiple Key Patents for Accuro™ and Accuro Locator™
October 13, 2016 | Press Release RIVANNA Secures $3.5 Million in Growth Financing
October 4, 2016 | Press Release RIVANNA Awarded $1.5M NIH Grant
42nd Annual ASRA Meeting
Visit us and demo an Accuro™ on April 6-8, 2017 in San Francisco, CA.
Mid-Atlantic Societies of Anesthesiologists 2nd Annual Conference
Visit us and demo an Accuro™ on April 22-23, 2017 in Georgetown, Washington DC.
ACOG Annual Clinical and Scientific Meeting
Visit us and demo an Accuro™ on May 6-9, 2017 in San Diego, California.
49th Annual SOAP Meeting
Visit us and demo an Accuro™ on May 10-14, 2017 in Bellevue, WA.
Why Accuro?The Accuro 3D spinal navigation technology by Rivanna Medical removes the guesswork that comes with blind needle guidance when you are performing epidurals or spinals because it is technology that is easy to use. Handheld, lightweight, untethered—the Accuro is the world’s first ultrasound-based system designed specifically to help you apply spinal and epidural anesthesia with 3D navigation of the lumbar spine. This innovative technology will improve your efficiency and instill confidence and comfort in the patients you treat.
Easy to Use, First-attempt Success.Accuro’s automatic detection of epidural location and depth makes it easy for you to administer spinal anesthesia. First time, every time.
IDENTIFYING EPIDURAL SPACE
*M. Tiouririne, et al., “Imaging performance of a handheld ultrasound system with real-time computer-aided detection of lumbar spine anatomy: a feasibility study.” Investigative Radiology. 2017; 52(8): 1-8. Study was performed in the lumbar spine region for both obese and normal BMI subjects.